BLAST2GODIRACREMOVEPAMLCATMRMODELTESTMODELTESTMAFFTPHYLOBAYESTRANSSEQFRISCHBLASTFAMHAPRAXMLGARLISUNNYSNPPHREDLAMARCMRBAYESPAMLGAUSSIANPAUP
OPENBUGSPHASEPHREDPHRAPPHYMLPOYPREASSPROTTESTSIMWALK2STRUCTURESUNNYSNPP1TREEFINDERUNPHASEDRDALTONPSCLPPSCLCUSTOMBLASTHERVEPARSERNPMLE
The local organizing committee and the steering group of the Bacillus?ACT Conference are pleased to announce the 2007 Conference in Oslo, Norway. This is a fusion of two meetings otherwise known as the 7th International Conference on Anthrax, and the 5th International Workshop on the Molecular Biology of Bacillus cereus, B. anthracis, and B. thuringiensis. While the Anthrax Conference has been a biannual event since the Winchester meeting in 1989, the Bc/Ba/Bt workshop was first arranged in Oslo in 1997, and is this year. The mission of the conference is to bring together researchers involved in scientific research related to the physiology, genetics, genomics, molecular biology, and pathogenicity of these bacteria. NEW: A half-day training workshop will be given by the Bioinformatics Resource Center (BRC), The Institute for Genomic Research (TIGR), before the official start of the Bacillus?ACT conference on Sunday June 17th, to introduce the new Pathema?Bacillus resource (projected release date April 2007) to the Bacillus scientific community.
Source
--Kamran Shalchian-Tabrizi
The 15th Annual International Conference on Microbial Genomics will continue the tradition of bringing investigators from biology, technology and computer sciences together to discuss the most recent advances in microbial genomics. This year\'s series will continue to incorporate frontier areas including new microbial communities, metagenomics, structural proteomics, synthetic biology including the modeling and building of genetic circuits and metabolic pathways and conceivably the synthesis of completely artificial genomes. We will also emphasize a new topic for this conference, bioenergy. The combination of topics presented by leaders in the field, will offer attendees both the opportunity to build on existing genomic projects or initiate new research utilizing the latest technology. As with past meetings, we expect participants from a wide range of disciplines, including those from both academic and industrial institutions. In addition, this conference will provide fellowship awards to support graduate students in order to train the next generation of genomic experts. The conference will be held at the Riggs Alumni Center on the University of Maryland College Park campus from September 16 to 20, 2007
ProkaGENOMICS 2007 07. - 10.10.2007 Central Lecture Hall - Georg-August-University Goettingen Most of the genome research on prokaryotic organisms in Germany is currently performed within the framework of the three German GenoMik-Plus networks, which are funded by the Federal Ministry of Education and Research (BMBF) and have their centers located in Goettingen, Bielefeld and Wurzburg. The research within the networks is focused functional prokaryotic genome research with the goal to exploit genomic data for industrial production processes, agriculture and the control of infectious diseases. The GenoMik networks launched a series of conferences dealing with the rapidly evolving field of prokaryotic genome analysis in 2003. On behalf of the Scientific and the Organizing Committees, it is a great pleasure for me to invite scientists from all over the world to the 3rd European Conference on Prokaryotic Genomics (ProkaGENOMICS 2007) to be held October 7-10, 2007 at the Georg-August-University Goettingen, Germany. This meeting will be an excellent occasion to review the current state of prokaryotic genome research. You are cordially invited to attend the conference, listen to prominent scientists in this exciting field and present your work in short lectures or in poster sessions.
Bioinformatics forum for Young Scientists (BFYS) 11-13 May, 2007 Tromsoe BFYS-2007 will bring together young scientists working in Norwegian institutions and industry with bioinformatics. The purpose of this meeting is to create a forum where young bioinformaticians/computational biologists, that is to say Research Assistants, Post-Docs, PhD and Master students among others, can meet and share their research and get an overview of the groups working in this field in Norway.
--Torgeir Andersen Ruden
Potsdam, September 26-28, 2007 University of Potsdam Max Planck Institute for Molecular Plant Physiology Max Planck Institute for Molecular Genetics Berlin Center for Genome Based Bioinformatics The German Conference on Bioinformatics is an annual, international conference devoted to all topics in bioinformatics. Its tradition reaches back to 1985, and recent conferences have attracted up to 200 participants from all over the world. The 2007 conference is organized by the * University of Potsdam (http://www.uni-potsdam.de/), the * MPI for Molecular Plant Physiology (http://www-en.mpimp-golm.mpg.de/00-news/index.html), the * MPI for Molecular Genetics (http://www.molgen.mpg.de/) and the * Berlin Center for Genome Based Bioinformatics (http://www.bcbio.de/).
--Beatriz Decenciere
New Masters program in bioinformatics at Stockholm University. The masters program in bioinformatics is aimed at bright students with a bachelor degree in natural science and that has a driving interest to understand biology using computational methods. With the rapid growth of high throughput methods the amount of data and the complexity of the data in biology wildly surpasses that of any other discipline. Still the computational approaches are in their infancy and under rapid development. In contrast to most other masters programs in bioinformatics we are focused on understanding biology. Therefore several of the obligatory courses are aimed at understanding the molecular details of life, while other courses are focused on comparing genomes. All courses are given by professors that are performing world class research, in comparative genomics, protein bioinformatics, computational chemistry, molecular evolution and membrane proteins. The masters program is organized by Stockholm Bioinformatics Center, the largest bioinformatics center in Sweden. Several of the courses are given by professors at the Center for Biomembrane Research. The program is arranged by the Department of Biochemistry and Biophysics at Stockholm University In summary the bioinformatics masters provide a unique possibility to learn the most advanced methods to analyze complete genomes. Included in the program is one to two semesters of research at one of the affiliated groups, providing an unique chance to obtain research experience. These groups also recruit a number of PhD students every year.
A one-day event, presenting core bioinformatics services in the Oslo area and Bergen. This is a great opportunity to learn about the bio- informatics services available to you! More information at: www.bioportal.uio.no/bioserv.php
18-23 February 2007, BOLOGNA (Italy) TEACHERS: Patrick Aloy (Institute for Research in Biomedicine, Barcelona, ES), Alvis Brazma (EBI, Hinxton, UK), Soeren Brunak (Technical University of Denmark, Lyngby, DK), Giovanni De Micheli (Ecole Polytechnique Federale, Lausanne, CH), Diego Di Bernardo (TELETHON-TIGEM Foundation, Naples, It), Joaquin Dopazo (Centro de Investigacion Principe Felipe-CIPF, Valencia, ES), Roderic Guigo (IMIM/University Pompeu Fabra, Barcelona, ES), David T. Jones (University College, London UK), Arthur Lesk (PennState University, USA), Michal Linial (The Hebrew University of Jerusalem, IL), Marc A. Marti-Renom (Centro de Investigacion Principe Felipe-CIPF, Valencia, ES), Sven Panke (ETH, Zurich, CH), Juan F. Poyatos (Spanish National Cancer Research Centre-CNIO, Madrid, ES), Reinhard Schneider (EMBL, Heidelberg, DE), Luis Serrano (EMBL, Heidelberg, DE), Anna Tramontano (Universita La Sapienza, Roma, IT), Alfonso Valencia (Spanish National Cancer Research Centre-CNIO, Madrid, ES). SCIENTIFIC COMMITTEE: R. Casadio, D. Jones, A. Tramontano, A. Valencia. PROGRAMME COMMITTEE: L. Benini, R. Casadio, S. Cavalcanti, L. Margara ORGANIZING COMMITTEE: R. Casadio LOCAL COMMITTEE: P. Fariselli, P.L. Martelli, I. Rossi, G.Tasco, M. Vassura ORGANIZING SECRETARY AIRBBC/CIRB c/o Dept. of Biology, University of Bologna Via Irnerio 42, 40126, Bologna, ITALY. Tel: (+39) 051 2094005 Fax: (+39) 051 242576 For application send a short C.V. to school2007@biocomp.unibo.it
Computational Biology Unit Bergen Center for Computational Science (BCCS) UNIFOB AS (Bergen University Foundation) Thormoehlensgate 55 N-5008 Bergen, Norway. A fulltime position as service scientist is available within the Computational Biology Unit (CBU) at the Bergen Centre for Computational Science (BCCS), Unifob AS. BCCS is a research institute with 45 employees counting more than 10 different nationalities. CBU is a laboratory devoted to research in bioinformatics, and also provides services in bioinformatics to Norwegian researchers working within functional genomics. The service scientist recruited will work in the service group of CBU. Services offered by this group are for example: consultancy, assistance in data analysis, in writing computer programs, in designing and maintaining databases, in writing web interfaces to scientific programs. The group currently consists of two scientists and one programmer. The ideal candidate has a master degree in molecular biology or a related field, extensive experience in bioinformatics, programming skills in different languages, experience from different operating systems, knowledge of databases and web programming. Candidates with a master in computational science/informatics will also be considered. Extensive knowledge in molecular biology is required. Experience from bioinformatics or from related scientific fields is an advantage. The position is available preferably starting March 1st 2007. Please send the following documents to Nathalie Reuter by email (nathalie.reuter@cbu.uib.no ) and cc to Hilde Soelvberg (hilde.solvberg@bccs.uib.no ): - cover letter; - detailed CV (max. 3 pages); - contact information for two references. Applications which do not include all required documents will not be considered. Application deadline is January 31st .
ISMB/ECCB 2007 will be held in Vienna, Austria and is jointly hosted by the International Society for Computational Biology (ISCB) and the European Conference on Computational Biology (ECCB). The conference, July 21-25, is preceded by Special Interest Group Meetings (SIGs) on July 19 and July 20. ISMB/ECCB 2007 provides a multidisciplinary forum for disseminating the latest developments in bioinformatics. Bringing together over 2000 international scientists from the fields of computer science, molecular biology, molecular medicine, mathematics, and statistics the conference will focus on the development and application of advanced computational methods for biological problems. ISMB/ECCB 2007 is now accepting high-quality original research papers in any aspect of computational biology. The submission deadline is February, 2, 2007.
The Fourth International Meeting on Computational Intelligence Methods for Bioinformatics and Biostatistics, will be held in the wonderful location of Portofino Vetta (near Genova, Italy) from 7 to 10 July 2007. CIBB 2007 is jointly organized by - INNS, International Neural Network Society, SIG Bioinformatics - DSI, Dipartimento di Scienze dell\'Informazione, Unversita degli Studi di Milano. - DMI, Dipartimento di Matematica e Informatica, Universita di Salerno and in connection with WILF 2007 (http://wilf2007.disi.unige.it). If you would like to contribute then please send a paper no more than 6 pages long in pdf format within 31th January 2007 to the meeting submission website http://cibb07.dsi.unimi.it and a copy in attachment to infocibb07@dsi.unimi.it.
The complete works of one of history\'s greatest scientists, Charles Darwin, are being published online. The project run by Cambridge University has digitised some 50,000 pages of text and 40,000 images of original publications - all of it searchable. Surfers can even access downloadable audio files to use on MP3 players. The resource is aimed at serious scholars, but can be used by anyone with an interest in Darwin and his theory on the evolution of life. \"The idea is to make these important works as accessible as possible; some people can only get at Darwin that way,\" said Dr John van Wyhe, the projects director.
--Jan Haug Anonsen
The SIB PhD School in Bioinformatics, partially funded by a Pro*Doc Grant from the Swiss National Science Foundation, will start in October 2006 with 7 research students. The program will be mainly build on specific courses covering a wide-range of bioinformatics topics, workshops and scientific meetings to promote discussions and interactions among students and confirmed scientists from the SIB or the international community.
Blue biotech is getting into its stride, as the tools of genomics and high throughput screening are applied to unlock the chemical diversity of the oceans. Thus far marine, or blue biotech is an also ran next to its pharmaceutical, industrial and agricultural cousins. But last week Pharmamar, Europes leader in marine drug discovery and development submitted a new cancer treatment for approval, signalling a turning tide in the commercial prospects of marine biotechnology. Oceans cover about 70 percent of the earth and are home to thousands or possibly millions of species of plants and animals. But while plant and animal life on land is well documented, much of life in the seas remains uncharted territory. They may all be wet, but there is a huge variety of marine habitats from hot water vents to polar ice, and tidal rock pools to high pressure environments in the abyssal deeps. And now it transpires that microbial diversity in the oceans may be up to 100 times greater than previously estimated.
--Tellef Rygh
Europe is an explosive incubator of new biotechnological ideas, but growth is hampered by a severe lack of venture capita, an industry study comparing the biotechnology sector on both sides of the Atlantic has found. The report, produced on behalf of EuropaBio, the European Association for Bioindustries, compared the performance of 18 European countries with the United States. It found that, at the end of 2004, there were more than 2 100 biotech companies in Europe, but less than 2 000 in the United States. The number of new companies formed in Europe were nearly a 120 compared with less than 80 in the USA. However, in all other measures the transatlantic gap stretched the other way. This suggests that Europe is good at lighting the initial spark but less good at keeping the flame going. Europe is extraordinarily entrepreneurial, creating over 100 new small vibrant companies each year, observed Johan Vanhemelrijck, the secretary-general of EuropaBio. These companies must keep being vibrant, but they must stop being small. European biotech firms spend 7.6 billion on R&D, while their US counterparts sink a massive 21 billion, and the gap in revenue is similarly large, with US firms generating 41.5 billion, as opposed to 21.5 billion in Europe. One of the main problems is what EuropaBio calls chronic underfunding. Europes biotechnology project is in danger of foundering from the relative dearth of that most vital of fuels for innovation: money,\" the association warned in a statement.
This year marks the biotechnology industrys 30th anniversary, and the industry is finally starting to act its age. Biotech is a global powerhouse with over $60 billion in revenues and hundreds of marketed products, according to Donn Szaro of Ernst & Young, who spoke at the recent Massachusetts Biotechnology Council annual meeting. The industry is closer to reaching profitability than at any other time in its history. And the market valuations of its biggest players, including Amgen and Genentech, are approaching those of Big Pharma.
The development of CSH Protocols is a response to requests from scientists for authoritative information about techniques with a broad editorial scope, delivered through a state-of-the-art online interface. At this new site, you will find methods from Molecular Cloning along with selected protocols from many of our best-selling manuals, such as Cells and Antibodies, as well as protocols from Cold Spring Harbors renowned on-site courses. In addition, you will discover new cutting-edge protocols submitted by and commissioned from laboratories worldwide. A peer-reviewed online journal, CSH Protocols is updated monthly.
454 Life Sciences Corporation, a majority-owned subsidiary of CuraGen Corporation, and Roche Diagnostics today announced the launch of an updated version of the Genome Sequencer 20(TM) System. Version 1.02 of the Genome Sequencer 20 System comes with a bundle of improvements. The enhanced features of the Genome Sequencer 20 System, version 1.02 will yield several significant improvements in the way the system can be used and in the data that result. The increased accuracy of single reads, greater than or equal to 99%, will further increase the quality of consensus sequences. It will also considerably improve the confidence level of putative sequence deviations detected using heterozygote calling and ultra deep amplicon sequencing, which the companies plan to launch later this year.
Sigma-Aldrich has expanded its shRNA gene family sets in lentiviral format for direct use in gene silencing. The Mission TRC shRNA Human Kinases Gene Family is the second in a series of shRNA target sets that allows for rapid RNAi cell-based screens in mammalian systems not easily manipulated by traditional siRNA. The lentiviral transduction particle format eliminates the need to propagate bacterial cells, purify plasmid DNA or undertake the lengthy process of preparing virus, saving time and valuable resources.
Genomics integration solution Genedata Expressionist now works interoperatively with Ingenuity Systems Pathways Analysis application, according to an announcement made today by Genedata Inc. and Ingenuity Systems. According to the companies, researchers will now experience a seamless workflow when linking genome-wide experimental data with disease-relevant information about genes, proteins and biological pathways. Website: www.genedata.com.
Progeniq announced a universal version of its third-generation BioBoost bioinformatics data processing accelerator for Mac OS X version 10.4 \"Tiger\". BioBoost accelerators provide hardware processing for the most computationally intensive applications. Used on Intel-based Macs, BioBoost can make bioinformatics applications up to 10x-50x faster than a typical processor, according to the company. By utilizing field-programmable gate array technology, the processor can rewire itself on the fly according to the application that needs to be accelerated. This allows a single hardware accelerator to speed up any number of supported applications. Website: www.progeniq.com.
Scientists will soon be able to access a vast collection of biomedical research publications at the touch of a button. Based on a model used in the United States, UK PubMed Central will provide free access to an online digital archive of peer-reviewed research papers in the medical and life sciences...
BioBoost from Progeniq - which accelerates computationally intensive bioinformatics applications, at up to 50x-100x faster than on a typical workstation processor. The BioBoost uses Field Programmable Gate Array (FPGA) technology on a USB 2.0 or PCI based device, to accelerate applications at significantly lower cost. http://www.progeniq.com.
FUGE advertise 20 million NOK for user-controlled innovation projects. Application deadline is 31st of August. See \"source\" for more details (only in norwegian).
Solexa, one of the leaders in the race to develop next-generation commercial genomic sequencing technology, has announced a partnership with Invitrogen Corp. to provide reagents for Genome Analysis System. Solexa announced last year that it would begin shipping its bench-top DNA sequencing unit during 2006. The instrument, which will be roughly equal in cost to conventional high-throughput capillary sequencing machines, has the potential to generate over a billion bases of DNA sequence data per run. CEO John West has stated that he estimates that one machine can sequence an entire human genome in about three months for approximately $100,000.
Applied Biosystems (AB) has completed the acquisition of Massachusetts-based genetic analysis company Agencourt Personal Genomics (APG) for $120 million, and hopes to bring the company\'s novel next-generation sequencing technology to market next year. Impressively named the Supported Oligo Ligation Detection (SOLiD) process for massively parallel sequencing by stepwise ligation, the technology is an extremely high throughput approach to DNA/RNA analysis. Applications include de novo genome sequencing, medical sequencing, gene expression and high throughput genotyping.
The European Science Foundation has launched the EuroBioFund initiative to promote, fund, and coordinate basic life science research in the European Union. Conceived at a December 2004 conference held to explore European funding synergies, the EuroBioFund has three main vehicles and objectives: - EuroBioForum, an annual conference, will provide a platform for networking and brokerage among funding organizations and researchers. - EuroBioGenerator will help organize and generate research programs on a European scale and scope. - EuroBioAccess will help develop joint investments and funding of life science research.
The discovery, if confirmed, could open new insights into the higher order control of the genes, like the critical but still mysterious process by which each type of human cell is allowed to activate the genes it needs but cannot access the genes used by other types of cell.
Vital-IT, through funding provided by the EU 6th Framework Programme, is pleased to invite proposals for cost-free use of its Integrated Computational Genomics Resource from individuals, institutions and companies from any of the EU Member and Associated States. Visiting developers may stay for a period from one week to two months at Vital-IT, with a likely average of one month. Their activities may include the development of new software for HPC applications in life-science, parallelization and optimiziation of existing software for the specific hardware architecture of Vital-IT, and large data analysis projects making use of the rich database collection offered by this facility. They will be provided with office space, free access to all hardware and software resources required by the project, and technical assistance from Vital-IT staff. Visiting developers will be selected primarily on the basis of a project proposal that will be evaluated by a review panel including external experts in high performance computing, bioinformatics and genomics, including representatives from industry.
Geneva, Switzerland July 19, 2006 - Geneva Bioinformatics (GeneBio) SA and the Swiss Institute of Bioinformatics (SIB) today announced a strategic partnership involving GeneBios e-Proxemis, a Web-based bioinformatics learning portal for proteomics. Under the terms of the agreement, e-Proxemis will become the centralized educational platform for the renowned ExPASy server hosted by the SIB, thus offering to the scientific community a diverse array of tailored learning all from a single location. This alliance is the latest in a string of collaborations between GeneBio and the SIB, which also includes GeneBios Phenyx MS data analysis platform, the Melanie gel analysis software and the SIBs renowned proteomics databases Swiss-Prot, PROSITE and SWISS-2DPAGE. e-Proxemis is a bioinformatics learning portal for proteomics that enables life scientists to master available resources essential for conducting proteomics research and becoming a key bioinformatics resource within their workplace. Users advance, via their own personalized workspace, through increasingly demanding scenarios and case studies with access to an impressive number of tutorials on a variety of resource tools and databases. Scientists can test their knowledge throughout the learning process and are consequently directed towards further scenarios, case studies and resources. New coursework is added on a regular basis, ensuring a reservoir of fresh data for future learning sessions.
ScanBalt campus (SBC) is a pilot project aimed at creating a critical mass in research and education within some selected scientific areas within biotechnology and life science. In the project 31 universities, hospitals and companies from 10 countries in Northern Europe unite to increase the mobility of students, lecturers and researchers within the ScanBalt region. The project pioneers in putting the Bologna process into practice within a large network. Furthermore, SBC aims at being a model for a trans-national and trans-sectorial organization, based on education, research and development. June 13 2006, The ScanBalt Campus website www.scanbaltcampus.org was launched at the mid-term conference in Berlin. The site contains all information on the project plus a student room, a press room, a career database and a research and education database.
The minutes of the meeting with FUGE (Functional genomics) and the institutions are available, click on \"source\" below.
Need help with analysis and interpretation of genomic data? STATGEN-CONSULT is a statistical supervision and consulting service in genomics available to UiO researchers. Please take a look at their homepage by clicking on \"source\" below this text.
FUGE (Functional genomics in Norway) awards 18 research projects financial support that totally amount to 118 million norwegian kroner. This round many very good applications competed for support of research projects within functional genomics . Sixty of 126 evaluated applications were in the A-category, meaning very good and worthy of support. Click on \"source\" below to find more information (only in norwegian).
Boris Lenhard at FUGEs national technology platform for bioinformatics in Bergen, is one of three main authors of a recently published article in the recognized journal Nature Genetics. The article is a path-breaking work that has mapped our genes \"start buttons\". Here is a link to the article: http://www.nature.com/ng/journal/v38/n6/full/ng1789.html Click on the link below to find more information (only in norwegian).
The FUGE programme is due to finish its first period and move on to FUGE II. FUGEs programme board have planned the process towards FUGE II. More information (only in norwegian) can be found by clicking on the \"source\" link below.
Free public access to Europes leading biological databases will be guaranteed under a 16.7 million EU project called FELICS Free European Life-science Information and Computational Services, launched this month. The European Molecular Biology Laboratorys European Bioinformatics Institute (EBI) will lead FELICS, in partnership with the Swiss Institute for Bioinformatics, the University of Cologne, Germany, and the European Patent Office. The aim is to develop, enhance and interlink the most important data sources and make them more accessible to the scientific community worldwide. This award, under Framework Programme 6, is the largest ever for computing infrastructure to support biological research.
The use of computers to advance human disease research known as bioinformatics has received a major boost from researchers at the La Jolla Institute for Allergy & Immunology (LIAI), who have used it to successfully predict immune response to one of the most complex viruses known to man the vaccinia virus, which is used in the smallpox vaccine. Immune responses, which are essentially how the body fights a disease-causing agent, are a crucial element of vaccine development. We are excited because this further validates the important role that bioinformatics can play in the development of diagnostic tools and ultimately vaccines, said Alessandro Sette, Ph.D., an internationally known vaccine expert and head of LIAIs Emerging Infectious Disease and Biodefense Center. We\'ve shown that it can successfully reveal with a very high degree of accuracy the vast majority of the epitopes (targets) that would trigger an effective immune response against a complex pathogen. Bioinformatics holds significant interest in the scientific community because of its potential to move scientific research forward more quickly and at less expense than traditional laboratory testing.
Biomatters announces an advanced application Geneious Pro AUCKLAND, New Zealand, 06 June 2006: The launch of Geneious Pro in the third quarter of 2006 will make it possible for bioinformatics data sharing to happen easily. Announcing Geneious Pro, Daniel Batten, CEO of Biomatters, the company that created Geneious, said, The launch of Geneious Pro will be a real answer to the needs of bioinformaticians and scientists when it comes to a bioinformatics application. Geneious Pro will deliver on many researchers dream, providing a complete set of tools to process data from sequence chromatograms through to sequence alignment and sequence analysis in a way any molecular biologist will find logical and intuitive, not to mention fast. We have also moved to the next key step in the evolution of Geneious with our team providing users with the ability to share information through P2P (peer-to-peer) collaboration. The P2P function has the ability to access information across a large number of data sources, co-authors and peer-collaborators in a way which is trusted, secure and timely. Geneious P2P removes the need for central servers or configuration setup, which means installation is automatic, collaboration is flexible and users are mobile. Researchers can find out more about Geneious at www.geneious.com
BIT (in coorporation with CBO) proudly presents a new news and seminars page, where selected people may post interesting news and seminars. This is a start of an effort to collect interesting news and seminars from all over the eastern region of Norway, by distributing the effort to keep it up to date. We currently have this on the bioportal home-page, but we wish to make this into a biocomputing/applied bioinformatics/bioinformatics news and seminars page. If a need is presented we will also provide other pages such as a course page. If you would like to have access to posting news and seminars, you need an bioportal user account and special permission from us. An email to bioportal-drift@usit.uio.no documenting a need, will probarbly give this permission. You may also contribute a logo to be displayed along with your news, but this is no nescesity. I hope you will join us in this effort, making this an interesting place to visit to find out what is happening in the eastern region of Norway.
